BRIEF-Aquinnah receives $10 mln investment from Pfizer, Abbvie
April 25, 2017 at 08:31 AM EDT
* Aquinnah Pharmaceuticals receives $10 million investment from Pfizer and Abbvie to research breakthrough approach to neurodegenerative disease